Reference
Ariel Stern, “Regulatory Incentives for Innovation: The FDA’s Breakthrough Therapy Designation”, Workshop: Innovation, regulation and organization in healthcare, Paris, 2022, revised June 10, 2026.
See also
Published in
Workshop: Innovation, regulation and organization in healthcare, Paris, 2022, revised June 10, 2026